Single-Dose Rivaroxaban-Induced Acute Liver Injury.
Publication
, Journal Article
Verheyen, E; Kileci, JA; Mathew, JP
Published in: Am J Ther
2019
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Am J Ther
DOI
EISSN
1536-3686
Publication Date
2019
Volume
26
Issue
4
Start / End Page
e538 / e540
Location
United States
Related Subject Headings
- Rivaroxaban
- Male
- Liver Failure, Acute
- Liver
- Hypertension
- Humans
- Factor Xa Inhibitors
- Drug Administration Schedule
- Disease Progression
- Chemical and Drug Induced Liver Injury
Citation
APA
Chicago
ICMJE
MLA
NLM
Verheyen, E., Kileci, J. A., & Mathew, J. P. (2019). Single-Dose Rivaroxaban-Induced Acute Liver Injury. Am J Ther, 26(4), e538–e540. https://doi.org/10.1097/MJT.0000000000000799
Verheyen, Elijah, John A. Kileci, and Joseph P. Mathew. “Single-Dose Rivaroxaban-Induced Acute Liver Injury.” Am J Ther 26, no. 4 (2019): e538–40. https://doi.org/10.1097/MJT.0000000000000799.
Verheyen E, Kileci JA, Mathew JP. Single-Dose Rivaroxaban-Induced Acute Liver Injury. Am J Ther. 2019;26(4):e538–40.
Verheyen, Elijah, et al. “Single-Dose Rivaroxaban-Induced Acute Liver Injury.” Am J Ther, vol. 26, no. 4, 2019, pp. e538–40. Pubmed, doi:10.1097/MJT.0000000000000799.
Verheyen E, Kileci JA, Mathew JP. Single-Dose Rivaroxaban-Induced Acute Liver Injury. Am J Ther. 2019;26(4):e538–e540.
Published In
Am J Ther
DOI
EISSN
1536-3686
Publication Date
2019
Volume
26
Issue
4
Start / End Page
e538 / e540
Location
United States
Related Subject Headings
- Rivaroxaban
- Male
- Liver Failure, Acute
- Liver
- Hypertension
- Humans
- Factor Xa Inhibitors
- Drug Administration Schedule
- Disease Progression
- Chemical and Drug Induced Liver Injury